Literature DB >> 2066707

Cardiovascular risk factors in young snuff-users and cigarette smokers.

M Eliasson1, D Lundblad, E Hägg.   

Abstract

We studied cardiovascular risk factors in 21 young men who were habitual snuff-users, and compared them with the same risk factors in 18 non-tobacco-users and 19 cigarette smokers of the same age and body mass index. Both snuff-users and smokers showed increased levels of alcohol and coffee consumption and a decreased level of physical exercise compared to non-users. Both groups of tobacco-users showed increased serum insulin levels compared to the control group at similar blood glucose concentrations. In contrast to the smokers, snuff-users showed no significant elevation of diastolic blood pressure, haemoglobin concentrations, white cell count, serum cholesterol or triglyceride levels. Snuff users had higher plasma fibrinogen levels than non-users (P = 0.07). The use of snuff by young men appears to have less impact than smoking on cardiovascular risk factors, with the possible exception of elevated serum insulin and plasma fibrinogen levels.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2066707     DOI: 10.1111/j.1365-2796.1991.tb00401.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  17 in total

Review 1.  Smokeless tobacco and cardiovascular disease in low and middle income countries.

Authors:  Rajeev Gupta; Nishant Gupta; R S Khedar
Journal:  Indian Heart J       Date:  2013-07-16

2.  Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers.

Authors:  G Bolinder; L Alfredsson; A Englund; U de Faire
Journal:  Am J Public Health       Date:  1994-03       Impact factor: 9.308

3.  Determination of heavy metals in the common smokeless tobacco afzal in oman.

Authors:  Nawal Al-Mukhaini; Taher Ba-Omar; Elsadig Eltayeb; Aisha Al-Shehi
Journal:  Sultan Qaboos Univ Med J       Date:  2014-07-24

4.  Tobacco and myocardial infarction: is snuff less dangerous than cigarettes?

Authors:  F Huhtasaari; K Asplund; V Lundberg; B Stegmayr; P O Wester
Journal:  BMJ       Date:  1992-11-21

5.  Biomarkers of Potential Harm among Adult Cigarette and Smokeless Tobacco Users in the PATH Study Wave 1 (2013-2014): A Cross-sectional Analysis.

Authors:  Joanne T Chang; Juan C Vivar; Jamie Tam; Hoda T Hammad; Carol H Christensen; Dana M van Bemmel; Babita Das; Uliana Danilenko; Cindy M Chang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-05-04       Impact factor: 4.254

6.  Missed opportunities for tobacco use screening and brief cessation advice in South African primary health care: a cross-sectional study.

Authors:  Olufemi B Omole; Kabilabe N W Ngobale; Olalekan A Ayo-Yusuf
Journal:  BMC Fam Pract       Date:  2010-11-29       Impact factor: 2.497

7.  Smoking effect on ischemic heart disease in young patients.

Authors:  Khaled Hbejan
Journal:  Heart Views       Date:  2011-01

8.  Study of cardiovascular disease biomarkers among tobacco consumers. Part 3: evaluation and comparison with the US National Health and Nutrition Examination Survey.

Authors:  Kristin M Marano; Steven J Kathman; Bobbette A Jones; Brian K Nordskog; Buddy G Brown; Michael F Borgerding
Journal:  Inhal Toxicol       Date:  2015-03-19       Impact factor: 2.724

9.  Association of exclusive smokeless tobacco consumption with hypertension in an adult male rural population of India.

Authors:  Ambarish Pandey; Nivedita Patni; Sasmit Sarangi; Mansher Singh; Kartavya Sharma; Ananth K Vellimana; Somdutta Patra
Journal:  Tob Induc Dis       Date:  2009-11-24       Impact factor: 2.600

10.  Effects of smokeless tobacco "Maras powder" use on nitric oxide and cardiovascular risk parameters.

Authors:  Aytekin Guven; Fatma Tolun
Journal:  Int J Med Sci       Date:  2012-10-25       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.